| 000 | 01621 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250512210057.0 | ||
| 264 | 0 | _c19840330 | |
| 008 | 198403s 0 0 eng d | ||
| 022 | _a0090-1229 | ||
| 024 | 7 |
_a10.1016/0090-1229(84)90002-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAiuti, F | |
| 245 | 0 | 0 |
_aA placebo-controlled trial of thymic hormone treatment of recurrent herpes simplex labialis infection in immunodeficient host: results after a 1-year follow-up. _h[electronic resource] |
| 260 |
_bClinical immunology and immunopathology _cJan 1984 |
||
| 300 |
_a11-8 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aHerpes Labialis _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunologic Deficiency Syndromes _xcomplications |
| 650 | 0 | 4 | _aLeukocyte Count |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPlacebos _xtherapeutic use |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 |
_aSimplexvirus _ximmunology |
| 650 | 0 | 4 | _aT-Lymphocytes |
| 650 | 0 | 4 |
_aThymus Extracts _xadverse effects |
| 700 | 1 | _aSirianni, M C | |
| 700 | 1 | _aFiorilli, M | |
| 700 | 1 | _aPaganelli, R | |
| 700 | 1 | _aStella, A | |
| 700 | 1 | _aTurbessi, G | |
| 773 | 0 |
_tClinical immunology and immunopathology _gvol. 30 _gno. 1 _gp. 11-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0090-1229(84)90002-3 _zAvailable from publisher's website |
| 999 |
_c6320996 _d6320996 |
||